|
Ten VC Predictions for 2010: Outrunning The Bear
|
|||||
|
He who loses less, wins? Venture capital in the 2000s was much akin to the joke about the two campers who cross paths with a bear. As the angry bear begins charging out of the woods towards the campers, the first camper starts putting his sneakers on. The other camper screams, “It’s no use, we’ll never be able to outrun the bear!” And the first camper yells back, “I don’t need to outrun the bear, I just need to outrun you!” Over the past decade, venture capitalists could claim top-quartile performance just by showing smaller losses than the rest of the pack. Several VC-backed companies with valuations deep into the 9-digits opted for the M&A escape hatch (SunEdison, Optisolar), taking haircuts in the process. Other high-profile pioneers like GreenFuel closed up shop and called it a day. Even cleantech’s most promising ventures were unable to avoid the reset. Case in point: Solyndra, which just last month filed for its long-awaited IPO. The company’s valuation was recalibrated during its $286M Series F financing, priced at less than $4 per share, compared to a prior Series D-3 offering at $23 per share. 2) At least one famed VC partnership fractures or sees an orderly wind-down, with insider gossip eventually leaking out. The changing of the venture guard moves full steam ahead, as weak fund performance from the lost decade finally forces LPs to question historic allocations to “franchise funds”. 3) A large, non-traditional investor enters the venture fray, boasting a very long fund duration (~20 years) vehicle focused on science and technology. Commence discussion on whether the traditional 10-year fund life makes structural sense for early-stage life sciences and energy investments. 4) Stealthy cleantech companies unveil. After years of intrigue and speculation, not to mention tens to several hundred million dollars invested, several energy technology companies finally lift the curtain and introduce themselves to the world. Will the emperor be wearing clothes? 5) Spike in biotech M&A. December 2009 served as an excellent indicator of what’s to come, with more than $1 billion returned to venture funds through the acquisitions of Acclarent, Calixa and Gloucester. Expect this month’s JP Morgan healthcare conference to play host to the industry’s ultimate speed dating session. 6) Semiconductors regain luster. After years spent languishing as pond scum in the VC pool, the public market chip rebound finally extends to its capital-starved, private brethren. Expect several IPOs and profitable M&A for some of the largest revenue generators. 7) Solar failures litter VC landscape. Schumpeter’s gale of creative destruction blows through the 250+ private solar companies. A handful of heavily-funded solar PV and CPV companies flame out, while sector leaders like First Solar consolidate their market position. 9) Russian oligarchs and other foreign investors snap up late-stage U.S. tech. DST’s investments in Facebook and Zynga serve as a role model. Let’s hope they encounter more success than the sovereign funds that purchased big stakes in U.S. investment banks. 10) Return of the VC mystique. A counter-intuitive prediction, but one that reflects the above assumptions and data points. A select few IPO grand slams create massive returns and fanfare, sparking a resurgence of interest in the asset class. LPs actually begin to talk about new opportunities in venture capital! Peter Hebert is co-founder and managing partner of Lux Capital, focusing on investments in advanced materials and energy. You can read his past peHUB posts here.
Most Popular Posts |
![]() |
![]() |


















January 4th, 2010 at 4:45 pm
Your third trend already happened in 08 and 09 it was hedge funds what new dumb money is going to show up this year?